Tuesday, February 24, 2009

Grass-pollen Tablet Launched To Treat Severe Hay Fever In Children

Grazax®, a grass-pollen allergen tablet, has been launched for use in children and adolescents aged 5 to 17 by Allergy Company ALK-Abelló. Grazax is the only non-injection immunotherapy licensed to treat children suffering from severe hay fever caused by grass pollen allergy. Grazax has been available for use in adults in the UK since January 2007. It's a once daily, fast-melting tablet which is placed under the tongue. Read more ...

Lab-Made Proteins That Neutralize Multiple Strains Of Seasonal And Pandemic Flu Identified By Scientists

Scientists have identified a small family of lab-made proteins that neutralize a broad range of influenza A viruses, including the H5N1 avian virus, the 1918 pandemic influenza virus and seasonal H1N1 flu viruses. These human monoclonal antibodies, identical infection-fighting proteins derived from the same cell lineage, also were found to protect mice from illness caused by H5N1 and other influenza A viruses. Read more ...